| Financial Year |
March 31 2023 |
| Monetary Funds |
3,530,378,317.36 |
| Held-for-trading Financial Assets |
50,000,000.00 |
| Notes Receivable |
12,158,563.83 |
| Accounts Receivable |
2,204,821,791.49 |
| Advances to Suppliers |
95,837,646.82 |
| Other Receivables |
125,245,864.89 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,891,642,821.20 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
53,299,905.77 |
| Total Current Assets |
10,130,400,509.30 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
232,929,445.13 |
| Investment Properties |
46,717,120.76 |
| Fixed Assetes |
1,484,968,044.66 |
| Under-construction Projects |
3,576.42 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
138,820,372.66 |
| R&D expenses |
25,343,578.96 |
| Goodwill |
217,747,306.16 |
| Long-Term Deferred and Prepaid Expenses |
59,776,130.45 |
| Deferred Income Tax Assets |
595,430,602.29 |
| Other Non-Current Assets |
106,170,649.78 |
| Sub-Total of Non-Current Assets |
3,273,563,162.56 |
| Total Assets |
13,403,963,671.86 |
| Short-Term Loans |
809,476,411.21 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,120,677,057.74 |
| Accounts Payable |
1,272,066,088.33 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
50,530,425.11 |
| Taxes Payable |
59,010,792.12 |
| Interest Payable |
-- |
| Dividend Payable |
9,709,100.59 |
| Other payables |
236,343,490.05 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
57,682,263.53 |
| Other Current Liabilities |
22,395,374.06 |
| Sub-Total of Current Liabilities |
4,208,223,056.62 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
862,733.68 |
| Deferred Income Tax Liabilities |
50,545,672.61 |
| Other Non-Current Liabilities |
101,125,712.00 |
| Sub-Total of Non-Current Liabilities |
349,062,864.30 |
| Total Liabilities |
4,557,285,920.92 |
| Paid-In Capital(Or Share Stock) |
592,929,678.00 |
| Capital Surplus |
1,287,137,308.57 |
| Surplus Reserve |
307,468,498.16 |
| LESS:Treasury Stock |
101,125,712.00 |
| Undistributed Profits |
4,073,939,368.16 |
| Minority Stockholder's Interest |
2,685,315,864.17 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,161,361,886.77 |
| Owner's Equity（Stockholder's Equity） |
8,846,677,750.94 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
13,403,963,671.86 |
